The dose required to achieve targeted weight loss or glycemic control is a therapeutic dose, which may range between 1.7 mg and 2.5 mg
For drug interactions, the long half-life means semaglutide provides sustained GLP-1 receptor activation that can affect how your body handles other medications
Using GLP-1 short term without addressing the eating patterns that will need to sustain weight loss independently is unlikely to produce lasting results
In the case of semaglutide, compounding has expanded access during periods of drug shortage and provided options at different price points than branded products
However, the precise kinetics of selenium handover from Prx6 to SEPHS2, the structural determinants that govern selenium selectivity, and the extent to which Prx6 activity becomes rate-limiting during oxidative stress remain unclear
This includes proper hand washing, using drinking water, sanitizing utensils and equipment, and handling food correctly to avoid contamination